StonvexLoading…
StonvexStonvexStonvexCore line items from TTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $156.25M | $630.93M | $484.25M | $331.01M |
Operating Income | $12.82M | $55.39M | $52.89M | $24.52M |
Net Income | $8.32M | $3.00M | $19.50M | $15.35M |
EPS (Diluted) | $0.06 | $0.02 | $0.15 | $0.12 |
Total Assets | $662.35M | $675.76M | $655.17M | $645.58M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $35.47M | $72.63M | $67.15M | $68.75M |
Free Cash Flow OCF − CapEx | $-30.88M | $19.54M | $15.45M | $14.82M |
Shares Outstanding | 135.30M | 134.11M | 133.65M | 133.37M |